According to Athenex 's latest financial reports and stock price the company's current Operating Margin is -85.56%. At the end of 2021 the company had an Operating Margin of -153.24%.
Year | Operating Margin | Change |
---|---|---|
2021 | -153.24% | 66.21% |
2020 | -92.20% | -20.67% |
2019 | -116.22% | -18.34% |
2018 | -142.33% | -56.82% |
2017 | -329.62% | -21.49% |
2016 | -419.83% | 15.45% |
2015 | -363.65% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | -36.36% | -57.50% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | -8,391.15% | 9,707.33% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.